Latest California Healthline Stories
Medical Marijuana Linked To Modest Budget Benefits For Medicare Part D, Study Finds
A Health Affairs study determines that Part D spending went down slightly on prescription drugs for which medical marijuana is viewed as a possible alternative.
Viejos moteles cobran nueva vida ayudando a las personas sin hogar a sanar
El uso de moteles deteriorados para cuidar y albergar temporalmente a personas sin hogar recientemente dadas de alta del hospital ayuda a estabilizarlos de manera económica, previniendo retornos innecesarios y costosos a las salas de emergencia y a los hospitales.
California Suicide Hotlines Get Good Grades But Could Improve, Study Says
State-funded hotlines are helping callers, but little research exists to show that they actually prevent suicides.
Doctors Get Creative To Distract Tech-Savvy Kids Before Surgery
Anxiety before surgery can be dangerous for kids. Medication can help calm them down. But an anesthesiologist in California has come up with a safer, cheaper and much more entertaining alternative.
Vaccines Are Not Just For Kids
California’s leading physician organization is heading a drive to convince adults they need their vaccinations, too.
Sounds Like A Good Idea? Regulating Drug Prices
Presidential candidates from both parties have proposals they say would help lower the cost of prescription drugs. But most experts say that efforts to regulate prices might not end up saving much money.
Busting Myths About Mental Illness
Mental illness is common — and so are misperceptions about it. These too-often-believed myths can be harmful to you and your loved ones.
Inaccurate Provider Lists A Major Barrier To Care, Study Finds
Research published in Health Affairs shows that new patients were able to get an appointment with a primary care doctor less than 30 percent of the time.
‘Don’t Cut Me!’: Discouraged By Experts, Episiotomies Still Common In Some Hospitals
Overall rates are falling in California and nationally but data point to certain hospitals with extremely high percentages.
American ‘Stem Cell Tourists’ Don’t Have To Travel Abroad, Study Says
Treatments marketed as everything from anti-aging applications to therapies for degenerative diseases are increasingly available at commercial clinics in the U.S., but their growing numbers raise ethical and regulatory concerns in the scientific community.